Jacobi Capital Management LLC Dexcom Inc Transaction History

Jacobi Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $11,818 - $14,816	-91 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $426 - $572	4 Added 4.6%	91 $50,000
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $1,700 - $2,266	21 Added 31.82%	87 $37,000
Q1 2021 May 11, 2021	BUY	$84.79 - $104.74 $3,306 - $4,084	39 Added 144.44%	66 $24,000
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $1,404 - $1,881	18 Added 200.0%	27 $10,000
Q3 2020 Oct 30, 2020	BUY	$95.51 - $112.95 $477 - $564	5 Added 125.0%	9 $4,000
Q2 2020 Aug 04, 2020	SELL	$62.68 - $105.34 $231,414 - $388,915	-3,692 Reduced 99.89%	4 $2,000
Q2 2020 Jul 27, 2020	BUY	$62.68 - $105.34 $231,665 - $389,336	3,696 New	3,696 $2,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.